Article Menu
Need Help?
No Article Versions Notes Found
Cite
Harricharan, S.; Biederman, K.; Bombassaro, A.M.; Lazo-Langner, A.; Elsayed, S.; Fulford, A.; Delport, J.A.; Xenocostas, A. Adherence to, and Outcomes of, a Galactomannan Screening Protocol in High-Risk Hematology Patients. Curr. Oncol. 2018, 25, 139-145. https://doi.org/10.3747/co.25.3848
Harricharan S, Biederman K, Bombassaro AM, Lazo-Langner A, Elsayed S, Fulford A, Delport JA, Xenocostas A. Adherence to, and Outcomes of, a Galactomannan Screening Protocol in High-Risk Hematology Patients. Current Oncology. 2018; 25(2):139-145. https://doi.org/10.3747/co.25.3848
Chicago/Turabian StyleHarricharan, S., K. Biederman, A.M. Bombassaro, A. Lazo-Langner, S. Elsayed, A. Fulford, J.A. Delport, and A. Xenocostas. 2018. "Adherence to, and Outcomes of, a Galactomannan Screening Protocol in High-Risk Hematology Patients" Current Oncology 25, no. 2: 139-145. https://doi.org/10.3747/co.25.3848
APA StyleHarricharan, S., Biederman, K., Bombassaro, A. M., Lazo-Langner, A., Elsayed, S., Fulford, A., Delport, J. A., & Xenocostas, A. (2018). Adherence to, and Outcomes of, a Galactomannan Screening Protocol in High-Risk Hematology Patients. Current Oncology, 25(2), 139-145. https://doi.org/10.3747/co.25.3848
